Cathepsin V ( CTSV ) Shapes the Epigenetic–Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker
Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello, Rolando André Rios Villacis, Ana Paula Drummond Rodrigues, Edivaldo Herculano Correa de Oliveira · 2026
Read Cathepsin V ( CTSV ) Shapes the Epigenetic–Immune Landscape of Bladder Cancer and Emerges as a Noninvasive Biomarker by Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello, Rolando André Rios Villacis, Ana Paula Drummond Rodrigues, Edivaldo Herculano Correa de Oliveira (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13519135.txt.
Description
Wallax Ferreira and co-authors profile a protein cutter in 2026 as both driver and telltale of bladder cancer. Using public multi-layer data banks, they map how the cutter, CTSV, is controlled by gene marks and chemical tags, and how it lines up with tumor traits and immune mix.
The cutter ran high in bladder tumors, most in the flat, spread-prone kind, they report. High levels tracked with higher grade, spread to nodes and beyond, drug resistance, and shorter survival. Gene activity links tied it to the tumor's immune landscape as well. A mark that shows in tissue and tracks the course could, if it reaches fluids, sort patients by risk without a scope.
Catalog record
| CREATOR | Wallax Augusto Silva Ferreira, Fabio Albuquerque Marchi, Glauco Akelinghton Freire Vitiello, Rolando André Rios Villacis, Ana Paula Drummond Rodrigues, Edivaldo Herculano Correa de Oliveira |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |